Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-18

Clinical Trial Update: Measured Hypocretin Levels and Recovery After Hip Surgery

View source ↗

Summary

Stanford-led clinical trial update reporting on measured hypocretin (orexin) levels and recovery after hip surgery in patients with hip osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Osteoarthritis, Hip | Status: UNKNOWN